参考文献/References:
[1] TSENG C H,TAI T Y,CHONG C K,CHEN C J,LIN B J.Mortality in diabetic patients after lower extremity amputations[J].J Formos Med Assoc,1994,11(33):842-848.
[2] FOWKES F G,HOUSLEY E,RIEMERSMA R A,MACINTYRE C C,CAWOOD E H.Smoking,lipids,glucose intolerance,and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the edinburgh artery study[J].Am J Epidemiol,1992,135(4):331-340.
[3] BIRRER M.Macroangiopathy in diabetes mellitus[J].J Int Med Res,2001,30(2):168-174.
[4] JONSSON K B,FRYDKJAER-OLSEN U,GRAUSLUND J.Vascular changes and neurodegeneration in the early stages of diabetic retinopathy:Which Comes First?[J].Ophthalmic Res,2016,56(2):1-9.
[5] SELVIN E,ERLINGER T P.Prevalence of and risk factors for peripheral arterial disease in the United States[J].Circulation,2004,56(1):738-743.
[6] PASTERBAK R C,CRIQUI M H,BENJAMIN E J,FOWKES F G,ISSELBACHER E M.Atherosclerotic vascular disease conference:Writing Group I:epidemiology[J].Circulation,2004,109(21):2605-2612.
[7] ORCHARD T J,STRANDNESS D E Jr.Assessment of peripheral vascular disease in diabetes.Report and recommendations of an international workshop sponsored by the American heart association and the American diabetes association 18-20 September 1992,new Orleans,Louisian[J].Diabetes Care,1993,88(2):1199-1209.
[8] O’HARE A M,KATZ R,SHLIPAK M G,CUSHMAN M,NEWMAN A B.Mortality and cardiovascular risk across the ankle-arm index spectrum[J].Circulation,2006,113(3):388-393.
[9] KLEIN R,SHARRETT A R,KLEIN B E.The association of atherosclerosis,vascular risk factors,and retinopathy in adults with diabetes:the atherosclerosis risk in communities study[J].Ophthalmology,2002,109(7):1225-1234.
[10] CHEUNG N,SHARRETT A R,KLEIN R.Aortic distensibility and retinal arteriolar narrowing:the multi-ethnic study of atherosclerosis[J].Hypertension,2007,50(4)50:617-622.
[11] ALBERTI K G,ZIMMET P Z.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J].Diabet Med,1998,15(3):539-553.
[12] WILKINSON C P,FERRIS F L,KLEIN R E,LEE P P,AGARDH C D.Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J].Ophthalmology,2003,110(9):1677-1682.
[13] FISHBANE S,YOUN S,FLASTER E,ADAM G,MAESAKA J K.Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients[J].Am J Kidney Dis,1996,27(5):668-672.
[14] FOWKES F G,MURRAY G D,BUTCHER I.Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality:a meta-analysis[J].JAMA,2008,300(2):197-208.
[15] SODHI H S,SHRESTHA S K,RAUNIYAR R,RAWAT B.Prevalence of peripheral arterial disease by ankle-brachial index and its correlation with carotid intimal thickness and coronary risk factors in nepalese population over the age of forty years[J].Kathmandu Univ Med J,2007,15(4):12-15.
[16] WEATHERLEY B D,NELSON J J,HEISS G,CHAMBLESS L E,SHARRETT A R.The association of the ankle-brachial index with incident coronary heart disease[J].BMC Cardiovasc Disord,2007,7(2):3.
[17] LI J,LUO Y,XU Y,YANG J,ZHENG L.Risk factors of peripheral arterial disease and relationship between low ABI and mortality from all-cause and cardiovascular disease in Chinese patients with type 2 diabetes[J].J Hum Hypertens,2007,21(6):377-381.
[18] MAYFIELD J A,CAPS M T,BOYKO E J,AHRONI J H,SMITH D G.Relationship of medial arterial calcinosis to autonomic neuropathy and adverse outcomes in a diabetic veteran population[J].J Diabetes Compl,2002,16(2):165-171.
[19] TSUCHIYA M,SUZUKI E,EGAWA K,NISHIO Y,MAEGAWA H.Abnormal peripheral circulation in type 2 diabetic patients with normal ankle-brachial index associates with coronary atherosclerosis,large artery stiffness,and peripheral vascular resistance[J].Diabetes Res Clin Pract,2005,70(3):253-262.
[20] MCDERMOTT M M,LIU K,CRIQUI M H.Anklebrachial index and subclinical cardiac and carotid disease:the multi-ethnic study of atherosclerosis[J].Am J Epidemiol,2005,162(12):33-41.
[21] KEN-ICHI O,KAZUYA U,HIDEYUKI S,HIROSHI Y,KUNIHISA O.History of obesity as a risk factor for both carotid atherosclerosis and microangiopathy[J].Diabetes Res Clin Pract,2004,66(Suppl 1),165-168.
[22] KRISHNAN K,BATH P M.Interventions for deliberately altering blood pressure in acute stroke[J].Stroke,2015,46(2):30-31.
[23] RAMAN R,VAITHEESWARAN K,VINITA K.Is prevalence of retinopathy related to the age of on set of diabetes?[J].Ophthalmic Res,2011,45(3):36-41.
[24] KIM B K,KIM H C,HA K H,KIM D J.Application of new cholesterol guidelines to the Korean adult diabetic patients[J].J Korean Med Sci,2015,30(11):1612-1617.
[25] VALENSI P,AVIGNON A,SULTAN A,CHANU B,NGUYEN M T.Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes:a cross-sectional study[J].Cardiovasc Diabetol,2016,15(1):1-10.
[26] GIODANO C,ROBERTS R,KRENTZ K,BISSIG D,TALREJA D,KUMAR A,et al.Catalase therapy corrects oxidative stress induced pathophysiology in incipient diabetic retinopathy[J].Invest Ophthalmol Vis Sci,2015,56(5):3095-3102.
相似文献/References:
[1]杜玮 刘子扬 周艳艳 雒雷鸣.糖尿病视网膜病变与血清胆红素水平的关系[J].眼科新进展,2012,32(5):000.
[2]范松涛 卢建民.阿司匹林与糖尿病患者玻璃体出血以及玻璃体切割术疗效的相关性研究[J].眼科新进展,2012,32(11):000.
[3]李艳 李筱荣 袁佳琴 潘斌.糖尿病大鼠视网膜中VEGF、PEDF的表达与血-视网膜屏障损伤[J].眼科新进展,2013,33(1):000.
[4]李朝晖 崔治华 胡晓英 孟丽珠 张敬维.糖尿病视网膜病变激光面积与疗效的分析[J].眼科新进展,2013,33(2):000.
[5]冯冬梅 朱鸿 施彩虹.CXC趋化因子及其受体在糖尿病视网膜病变中的作用[J].眼科新进展,2013,33(6):000.
[6]牛淑玲.糖尿病视网膜病变患者HbAlc、FPG与血小板参数的变化及危险因素分析[J].眼科新进展,2013,33(7):000.
[7]毕春潮 王睿 王建洲 雷春灵 董晓娟 王小莉 薛晓辉.Ad-PEDF对糖尿病视网膜病变大鼠视网膜新生血管的抑制作用[J].眼科新进展,2013,33(8):000.
[8]杨萍 孙书明 李晓鹏.辛伐他汀对糖尿病视网膜病变和炎症因子的影响[J].眼科新进展,2013,33(8):000.
[9]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[10]李小璐 马雅玲.糖尿病视网膜病变大鼠视网膜VEGF和PEDF的动态表达[J].眼科新进展,2013,33(9):000.